Markus haacker (44 résultats)

Etat : very good. Gently used. May include previous owner's signature or bookplate on the front endpaper, sticker on back and/or remainder mark on text block.

Paperback. Etat : New.

Soft cover. Etat : Very Good. Just On Fine Paperback. No Blemishes.

Softcover. Etat : Bon. Edition 2004. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Good. Edition 2004. Ammareal gives back up to 15% of this item's net price to charity organizations.

Etat : Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In good all round condition. Dust jacket in good condition. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,700grams, ISBN:9780198718048. …

Etat : New.

Paperback or Softback. Etat : New. HIV and AIDS in South Asia: An Economic Development Risk. Book.

Etat : As New. Unread book in perfect condition.

Hardcover. Etat : Very Good. Etat de la jaquette : Very Good. Light rubbing/indenting to d/j. A Good Read ships from Toronto and Niagara Falls, NY - customers outside of North America please allow two to three weeks for delivery.; 9.2 X 6.2 X 0.7 inches; 304 pages.

Paperback. Etat : New. This book offers an original perspective on AIDS as a development issue in South Asia, a region with a heterogeneous epidemic and estimated national HIV prevalence rates of up to 0.5 percent. The analysis challenges the common perception of HIV and AIDS which has been shaped to a large extent by analysis of HIV and AIDS in other regions with much higher prevalence rates. Three risks to development are associated with HIV and AIDS in South Asia: the risk of escalation of concentrated epidemics, the economic welfare costs, and the fiscal costs of scaling up treatment.…

Etat : New.

Paperback. Etat : New.

Etat : As New. Unread book in perfect condition.

Paperback. Etat : New. "HIV/AIDS continues to take a tremendous toll on the populations of many countries, especially in sub-Saharan Africa. In some countries with high HIV prevalence rates, life expectancy has declined by more than a decade and in a few cases by more than two decades. Even in countries with HIV prevalence of around 5 percent (close to the average for sub-Saharan Africa), the epidemic can reverse gains in life expectancy and other health outcomes achieved over one or two decades. This volume highlights work conducted under the umbrella of a World Bank work program on "The Fiscal Dimension of HIV/AIDS," including country studies on Botswana, South Africa, Swaziland, and Uganda. It covers four aspects of the fiscal dimensions of HIV/AIDS: First, it aims for a comprehensive analysis of the fiscal costs of HIV/AIDS, with a wider scope than a costing analysis focusing on only the policy response to HIV/AIDS.Second, it embeds the analysis of HIV/AIDS costs in a discussion of the fiscal context, and interprets these costs as a quasi-liability, not a debt de jure, but a political and fiscal commitment that binds fiscal resources in the future and cannot easily be changed, and very similar to a pension obligation or certain social grants or services. Third, it develops tools to assess the (fiscal dimensions of) trade-offs between HIV/AIDS policies and measures that take into account the persistence of these spending commitments. Fourth, most of the fiscal costs of HIV/AIDS are ultimately caused by new infections, and this study estimates the fiscal resources committed (or saved) by an additional (or prevented) HIV infection. Building on these estimates, the analysis here is able to assess the evolving fiscal burden of HIV/AIDS over time.".…

Etat : New. In English.

Etat : New.

Etat : As New. Unread book in perfect condition.

paperback. Etat : New.

Etat : New. In English.

Etat : New.

Etat : As New. Unread book in perfect condition.

Soft cover. Etat : Very Good+. 344 pages in very good condition. Pages are clean and unmarked, with graphs and tables throughout. Page edges are lightly scuffed and smudged. Black softcovers with white and red titles, featuring a photograph of a mother and daughter on the front. Covers are scuffed and lightly scratched. Lightly worn around the edges. VG+/- -. Book.…

Taschenbuch. Etat : Neu. Neuware - This book offers an original perspective on AIDS as a development issue in South Asia, a region with a heterogeneous epidemic and estimated national HIV prevalence rates of up to 0.5 percent. The analysis challenges the common perception of HIV and AIDS which has been shaped to a large extent by analysis of HIV and AIDS in other regions with much higher prevalence rates. Three risks to development are associated with HIV and AIDS in South Asia: the risk of escalation of concentrated epidemics, the economic welfare costs, and the fiscal costs of scaling up treatment.…

Paperback. Etat : New. In shrink wrap. Looks like an interesting title.

Etat : New. Aims to identify three risks to development associated with HIV and AIDS in the South Asia region: the risk of escalation of concentrated epidemics, the economic welfare costs, and the fiscal costs of scaling up treatment.KlappentextrnrnThis.

Etat : New.

Etat : New. KlappentextrnrnHIV/AIDS continues to take a tremendous toll on the populations of many countries, especially in sub-Saharan Africa. In some countries with high HIV prevalence rates, life expectancy has declined by more than a decade and in a few.

Etat : As New. Unread book in perfect condition.

Etat : New.

Paperback. Etat : New. This book offers an original perspective on AIDS as a development issue in South Asia, a region with a heterogeneous epidemic and estimated national HIV prevalence rates of up to 0.5 percent. The analysis challenges the common perception of HIV and AIDS which has been shaped to a large extent by analysis of HIV and AIDS in other regions with much higher prevalence rates. Three risks to development are associated with HIV and AIDS in South Asia: the risk of escalation of concentrated epidemics, the economic welfare costs, and the fiscal costs of scaling up treatment.…